# Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma

> **NCT01004900** · PHASE3 · UNKNOWN · sponsor: **Singapore Eye Research Institute** · enrollment: 90 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **PROCEDURE:** Selective Laser Trabeculoplasty
- **DRUG:** Travoprost/ Timolol/ Azopt/ Brimonidine

## Key facts

- **NCT ID:** NCT01004900
- **Lead sponsor:** Singapore Eye Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2010-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004900, "Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01004900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*